VALSARTAN -MEDO 80 MG

Land: Israël

Taal: Engels

Bron: Ministry of Health

Koop het nu

Download Bijsluiter (PIL)
19-10-2021

Werkstoffen:

VALSARTAN

Beschikbaar vanaf:

A.L. MEDI-MARKET LTD.

ATC-code:

C09CA03

farmaceutische vorm:

FILM COATED TABLETS

Samenstelling:

VALSARTAN 80 MG

Toedieningsweg:

PER OS

Prescription-type:

Required

Geproduceerd door:

MEDOCHEMIE LTD, CYPRUS

Therapeutisch gebied:

VALSARTAN

therapeutische indicaties:

For treatment of hypertension. Valsartan-Medo is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan-Medo signicantly reduced hospitalisations for heart failure. There is no evidence that Valsartan-Medo provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan-Medo is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

Autorisatie datum:

2021-05-27

Bijsluiter

                                Page 1 of 3
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
VALSARTAN-MEDO 80 MG, VALSARTAN-MEDO 160 MG
Film-coated tablets
COMPOSITION:
Valsartan-Medo 80 mg
Film-Coated Tablets
Each film-coated tablet contains: Valsartan 80 mg
Valsartan-Medo 160 mg
Film-Coated Tablets
Each film-coated tablet contains: Valsartan 160 mg
INACTIVE AND ALLERGENIC INGREDIENTS: See section 6 “Further
Information”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE.
This leaflet contains concise information about the medicine. If you
have further questions, refer to the
doctor or pharmacist.
This medicine has been prescribed for the treatment of your ailment.
Do not pass it on to others. It may harm them, even if it seems to you
that their ailment is similar.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
VALSARTAN-MEDO 80 MG AND VALSARTAN-MEDO 160 MG are intended for the
treatment of hypertension. For the treatment of heart failure and to
reduce hospitalizations in patients
with intolerance to angiotensin converting enzyme inhibitors (ACEi).
For treatment following myocardial infarction, to improve survival.
•
Hypertension increases the workload of the heart and arteries. If the
hypertension is not treated, damage to the blood vessels of the brain,
heart and kidneys could result.
The result may cause a stroke, heart failure or kidney failure.
Hypertension increases the risk of heart attacks. Lowering blood
pressure to normal levels reduces the risk of
developing these disorders.
•
For the treatment of adult patients following a heart attack
(myocardial infarction), in order to improve survival and reduce
additional heart problems.
•
For the treatment of symptomatic heart failure in adult patients.
Heart failure includes shortness of breath and swelling of the legs
and feet due to fluid buildup. Heart failure
means that the heart muscle cannot pump blood strongly enough to
supply all the blood needed by the body.
T
                                
                                Lees het volledige document
                                
                            

Documenten in andere talen

Bijsluiter Bijsluiter Arabisch 19-10-2021
Bijsluiter Bijsluiter Hebreeuws 19-10-2021

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten